$VERU +180% 🚀 🔹 Veru is a biotech company focused on metabolic disease, obesity, oncology, and men’s health treatments 🧬 🔹 Monster move after Veru entered a

$VERU +180% 🚀 🔹 Veru is a biotech company focused on metabolic disease, obesity, oncology, and men’s health treatments 🧬 🔹 Monster move after Veru entered a clinical supply agreement with Novo Nordisk for Wegovy in its Phase 2b obesity study 💉 🔹 Trial will evaluate enobosarm with Wegovy to hel…